pH-sensitive polymeric nanoparticles to improve oral bioavailability of peptide/protein drugs and poorly water-soluble drugs.
暂无分享,去创建一个
[1] Qiang Zhang,et al. A silica-based pH-sensitive nanomatrix system improves the oral absorption and efficacy of incretin hormone glucagon-like peptide-1 , 2012, International Journal of Nanomedicine.
[2] H E Junginger,et al. Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[3] Yuan-Man Hsu,et al. Nanoparticles incorporated in pH-sensitive hydrogels as amoxicillin delivery for eradication of Helicobacter pylori. , 2010, Biomacromolecules.
[4] H. Sung,et al. Effects of chitosan-nanoparticle-mediated tight junction opening on the oral absorption of endotoxins. , 2011, Biomaterials.
[5] L. Heinemann,et al. Alternative routes of administration as an approach to improve insulin therapy: update on dermal, oral, nasal and pulmonary insulin delivery. , 2001, Current pharmaceutical design.
[6] T. E. Abraham,et al. Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan--a review. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[7] R. Gurny,et al. Pharmacokinetics of a novel HIV-1 protease inhibitor incorporated into biodegradable or enteric nanoparticles following intravenous and oral administration to mice. , 1995, Journal of pharmaceutical sciences.
[8] Tao Zhang,et al. Bioavailability and pharmacokinetics of cyclosporine A-loaded pH-sensitive nanoparticles for oral administration. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[9] Qiang Zhang,et al. Absorption mechanism of cyclosporine A loaded pH-sensitive nanoparticles in rats. , 2008, Journal of nanoscience and nanotechnology.
[10] Qiang Zhang,et al. A novel nanomatrix system consisted of colloidal silica and pH-sensitive polymethylacrylate improves the oral bioavailability of fenofibrate. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[11] I. Chen,et al. Biomedical nanoparticle carriers with combined thermal and magnetic responses , 2009 .
[12] Youjia Cao,et al. Multilayer nanoparticles with a magnetite core and a polycation inner shell as pH-responsive carriers for drug delivery. , 2010, Nanoscale.
[13] Yifeng Pan,et al. Acute oral toxicity evaluation of biodegradable and pH-sensitive hydrogel based on polycaprolactone, poly(ethylene glycol) and methylacrylic acid (MAA). , 2008, Journal of biomedical materials research. Part A.
[14] Geert Verreck,et al. Use of a screening method to determine excipients which optimize the extent and stability of supersaturated drug solutions and application of this system to solid formulation design. , 2007, International journal of pharmaceutics.
[15] Jianhua Hu,et al. Nanoparticles based on the complex of chitosan and polyaspartic acid sodium salt: preparation, characterization and the use for 5-fluorouracil delivery. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[16] Qiang Zhang,et al. Bioavailability and pharmacokinetics of sorafenib suspension, nanoparticles and nanomatrix for oral administration to rat. , 2011, International journal of pharmaceutics.
[17] Bror Svarfvar,et al. Drug Release from pH and Ionic Strength Responsive Poly(acrylic acid) Grafted Poly(vinylidenefluoride) Membrane Bags In Vitro , 2004, Pharmaceutical Research.
[18] Ping Gao,et al. Enhanced Oral Bioavailability of a Poorly Water Soluble Drug PNU‐91325 by Supersaturatable Formulations , 2004, Drug development and industrial pharmacy.
[19] R. Gurny,et al. pH-Dependent dissolving nano- and microparticles for improved peroral delivery of a highly lipophilic compound in dogs , 2001, AAPS PharmSci.
[20] John B. Shoven,et al. I , Edinburgh Medical and Surgical Journal.
[21] Jennifer M. Smith,et al. Involvement of protein kinase C in chitosan glutamate-mediated tight junction disruption. , 2005, Biomaterials.
[22] Filippos Kesisoglou,et al. Nanosizing--oral formulation development and biopharmaceutical evaluation. , 2007, Advanced drug delivery reviews.
[23] J. Leroux,et al. pH-sensitive unimolecular polymeric micelles: synthesis of a novel drug carrier. , 2003, Bioconjugate chemistry.
[24] I. W. Cheong,et al. Swelling and drug release behavior of tablets coated with aqueous hydroxypropyl methylcellulose phthalate (HPMCP) nanoparticles. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[25] Rainer H. Müller,et al. Nanosuspensions for the formulation of poorly soluble drugs: I. Preparation by a size-reduction technique , 1998 .
[26] S. Yuk,et al. Temperature-induced gel formation of core/shell nanoparticles for the regeneration of ischemic heart. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[27] Tse-Ying Liu,et al. Novel pH-sensitive chitosan-based hydrogel for encapsulating poorly water-soluble drugs. , 2010, Acta biomaterialia.
[28] Shirui Mao,et al. Peroral delivery of insulin using chitosan derivatives: a comparative study of polyelectrolyte nanocomplexes and nanoparticles. , 2007, International journal of pharmaceutics.
[29] T. Yen,et al. Biodistribution, pharmacodynamics and pharmacokinetics of insulin analogues in a rat model: Oral delivery using pH-responsive nanoparticles vs. subcutaneous injection. , 2010, Biomaterials.
[30] Qiang Zhang,et al. Preparation and characterization of insulin nanoparticles employing chitosan and poly(methylmethacrylate/methylmethacrylic acid) copolymer. , 2006, Journal of nanoscience and nanotechnology.
[31] J. Fletcher. Distribution , 2009, BMJ : British Medical Journal.
[32] Qiang Zhang,et al. pH-sensitive nanoparticles for improving the oral bioavailability of cyclosporine A. , 2004, International journal of pharmaceutics.
[33] Jan Van Humbeeck,et al. Influence of Preparation Methods on Solid State Supersaturation of Amorphous Solid Dispersions: A Case Study with Itraconazole and Eudragit E100 , 2010, Pharmaceutical Research.
[34] P. Gao,et al. Development of supersaturatable self-emulsifying drug delivery system formulations for improving the oral absorption of poorly soluble drugs , 2006, Expert opinion on drug delivery.
[35] A. Lamprecht,et al. Nanoparticles in inflammatory bowel disease: particle targeting versus pH-sensitive delivery. , 2006, International journal of pharmaceutics.
[36] Qiang Zhang,et al. Distribution, transition, adhesion and release of insulin loaded nanoparticles in the gut of rats. , 2007, International journal of pharmaceutics.
[37] L. Mattoso,et al. Preparation of chitosan nanoparticles using methacrylic acid. , 2008, Journal of colloid and interface science.
[38] Hsin‐Lung Chen,et al. Enteric-coated capsules filled with freeze-dried chitosan/poly(gamma-glutamic acid) nanoparticles for oral insulin delivery. , 2010, Biomaterials.
[39] Xuenong Zhang,et al. Preparation of an alternative freeze-dried pH-sensitive cyclosporine A loaded nanoparticles formulation and its pharmacokinetic profile in rats. , 2009, Die Pharmazie.
[40] Qiang Zhang,et al. Comprehensive studies on the interactions between chitosan nanoparticles and some live cells , 2011 .
[41] Lichen Yin,et al. Preparation, characterization, and oral delivery of insulin loaded carboxylated chitosan grafted poly(methyl methacrylate) nanoparticles. , 2009, Biomacromolecules.
[42] F. Cakalagaoglu,et al. Release behaviour and biocompatibility of drug-loaded pH sensitive particles. , 2006, International journal of pharmaceutics.
[43] Hsing-Wen Sung,et al. In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery. , 2009, Biomaterials.
[44] Yung-Chih Wu,et al. A novel pH-sensitive hydrogel composed of N,O-carboxymethyl chitosan and alginate cross-linked by genipin for protein drug delivery. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[45] Mohamed H. El-Shabouri,et al. Positively charged nanoparticles for improving the oral bioavailability of cyclosporin-A. , 2002, International journal of pharmaceutics.
[46] T. E. Abraham,et al. pH sensitive alginate-guar gum hydrogel for the controlled delivery of protein drugs. , 2007, International journal of pharmaceutics.
[47] Qiang Zhang,et al. Thymopentin-loaded pH-sensitive chitosan nanoparticles for oral administration: preparation, characterization, and pharmacodynamics. , 2006, Journal of nanoscience and nanotechnology.
[48] Lisa Brannon-Peppas,et al. Recent advances on the use of biodegradable microparticles and nanoparticles in controlled drug delivery , 1995 .
[49] R. Gurny,et al. pH-Sensitive Nanoparticles: An Effective Means to Improve the Oral Delivery of HIV-1 Protease Inhibitors in Dogs , 1996, Pharmaceutical Research.
[50] H. Takeuchi,et al. pH-Sensitive nanospheres for colon-specific drug delivery in experimentally induced colitis rat model. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[51] Dongmei Cun,et al. Preparation of insulin loaded PLGA-Hp55 nanoparticles for oral delivery. , 2007, Journal of pharmaceutical sciences.
[52] M. Radosz,et al. pH-responsive nanoparticles for cancer drug delivery. , 2008, Methods in molecular biology.
[53] H. Junginger,et al. Intestinal Absorption of Octreotide Using Trimethyl Chitosan Chloride: Studies in Pigs , 2001, Pharmaceutical Research.
[54] S. Howell,et al. Acidic hydrolysis of N-Ethoxybenzylimidazoles (NEBIs): potential applications as pH-sensitive linkers for drug delivery. , 2007, Bioconjugate chemistry.
[55] Chi H. Lee,et al. pH-sensitive Eudragit nanoparticles for mucosal drug delivery. , 2011, International journal of pharmaceutics.
[56] N. Peppas,et al. Nanoscale analysis of protein and peptide absorption: insulin absorption using complexation and pH-sensitive hydrogels as delivery vehicles. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[57] C. H. Goh,et al. Comparative drug release studies of two cationic drugs from pH-responsive nanogels. , 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[58] A. Nokhodchi,et al. Development of pH-sensitive Insulin Nanoparticles using Eudragit L100-55 and Chitosan with Different Molecular Weights , 2010, AAPS PharmSciTech.
[59] Hsing-Wen Sung,et al. A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery. , 2011, Biomaterials.
[60] Mark Voorneveld,et al. Preparation , 2018, Games Econ. Behav..
[61] Wei Yang,et al. Targeted Intestinal Delivery of Supersaturated Itraconazole for Improved Oral Absorption , 2008, Pharmaceutical Research.
[62] Jiun-Jie Wang,et al. Self‐Assembled pH‐Sensitive Nanoparticles: A Platform for Oral Delivery of Protein Drugs , 2010 .
[63] S. Vandermerwe. Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs , 2004 .
[64] Hui Xu,et al. Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo. , 2002, International journal of pharmaceutics.
[65] K. Tam,et al. Application of drug selective electrode in the drug release study of pH-responsive microgels. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[66] S. Sajeesh,et al. Novel pH responsive polymethacrylic acid-chitosan-polyethylene glycol nanoparticles for oral peptide delivery. , 2006, Journal of biomedical materials research. Part B, Applied biomaterials.
[67] R. Gurny,et al. Oral bioavailability of a poorly water soluble HIV-1 protease inhibitor incorporated into pH-sensitive particles: effect of the particle size and nutritional state. , 2000, Journal of controlled release : official journal of the Controlled Release Society.